Jiaqiang Zhang

No ORCID on file · 2 papers in corpus
rct 2025
Frontiers in medicine ·doi:10.3389/fmed.2025.1604790

BACKGROUND: This phase 2 trial comprised dose exploration (stage 1) and dose confirmation stages (stage 2) to determine the safety and efficacy of HSK21542 in patients undergoing laparoscopic abdominal surgery. METHODS: In stage 1, patient…

other 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.897968

Early diagnosis of cancer is crucial to initiate prompt treatment for better patient outcomes. The host immune function and its associated modulators are considered to be potential biomarkers for early cancer diagnosis. Immune and immune-ch…